News
BioTox Sciences Attends the Society of Toxicology: Annual Meeting and Toxicology Expo
Washington, D.C. March 6, 2011 – BioTox Sciences attends the Society of Toxicology: Annual Meeting and Toxicology Expo at the Walter E. Washington Convention Center.
Read MoreBioTox Sciences Attends the Drug Delivery and Formulation America Summit
San Diego, CA. April 27-28, 2011 – BioTox Sciences attends the Drug Delivery and Formulation America Summit.
Read MoreBioTox Sciences Attends the American Association of Pharmaceutical Scientist Annual Meeting and Exposition
Atlanta, GA. September 28, 2011 — BioTox Sciences Attends the American Association of Pharmaceutical Scientist Annual Meeting and Exposition in Atlanta, Georgia.
Read MoreBioTox Sciences Attends the American College of Toxicology Annual Meeting
Phoenix, AZ. November 6, 2011 – BioTox Sciences attends the American College of Toxicology’s Annual Meeting in Phoenix, Arizona.
Read MoreBioTox Sciences (BTS) Deploys eStudy™ Hosted Solution for Management of GLP & Non-GLP Preclinical Studies
CARY, N.C., March 9, 2011 /PRNewswire/ — iAdvantage Software, Inc., a leading solutions provider for managing development and pre-clinical life science studies, today announced that BioTox Sciences (BTS), a GLP Contract Research Organization, headquartered in San Diego, California, is deploying the eStudy™ hosted solution to manage its GLP and Non-GLP preclinical/nonclinical studies. (Logo: http://photos.prnewswire.com/prnh/20110309/CL62195LOGO )…
Read MoreApricus Biosciences Sells Bio-Quant CRO Subsidiary to BioTox Sciences
Company to Focus on Generation of Revenues From Commercialization of Drug Pipeline Based on NexACT(R) Delivery Technology SAN DIEGO, July 6, 2011 (GLOBE NEWSWIRE) — Apricus Biosciences, Inc. (“Apricus Bio”) (Nasdaq:APRI) announced today that it has sold its wholly-owned subsidiary, Bio-Quant, Inc. (“Bio-Quant”), a specialty biotechnology Contract Research Organization (“CRO”), to BioTox Sciences (“BioTox”), a…
Read MoreBioTox Sciences FDA Audit News
SAN DIEGO, January 31, 2012 – BioTox Sciences is pleased to share that their most recent FDA audit was met with no deviations from the regulations. No observations, 483’s or findings were noted in the three and a half day inspection.
Read MoreBioTox Sciences Attends the Society of Toxicology: Annual Meeting and Tox Expo
San Francisco, March 11-15, 2012 – BioTox Sciences attends the SOT’s Annual Meeting and Toxicology Expo at the Moscone Convention Center in San Francisco, California. The Annual Meeting is the premier event in the Toxicology community that addresses the latest achievements in Toxicology that have been accomplished within the last year.
Read MoreBioTox Sciences Attends the American Association for Cancer Research Annual Meeting
CHICAGO, March 31, 2012 – BioTox Sciences attends the American Association for Cancer Research Annual Meeting in Chicago, Illinois. The American Association for Cancer Research Annual Meeting serves as the culmination of all new advancements and findings from all major areas of cancer research from the past year.
Read MoreBioTox Sciences Attends The Drug Discovery Chemistry Meeting
SAN DIEGO, APRIL 17-19, 2012 – BioTox Sciences attends the Cambridge Healthtech Institue’s Seventh Annual Drug Discovery Chemistry at Hilton San Diego Resort & Spa.
Read More